Accordingly, Ccnd1 is classified as an oncogene frequently amplified in many types of neoplasia, and different cancer treatments with Cdk4/6 inhibitors such as Palbociclib have been approved to block this function. The gene discussed is CCND1; the disease is neoplasm.